MENU
XFOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
X4 Pharmaceuticals (XFOR) Ownership - Who owns X4 Pharmaceuticals?
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
61 North Beacon Street
Phone
+1 857 529-8300
Employees
93
Web
https://www.x4pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.42M
P/E Ratio
1.75
Total Cash
86.95M
Projected Growth
N/A
Total Debt
78.04M
Revenue
31.36M
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash/Share
15.02
Total Debt/Equity
N/A
Revenue/Share
4.64 USD as % of share price
Fundamentals
XFOR
Capitalization
21.4M
P/E Ratio
1.75
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash
87M
Total Cash/Share
15.02
Total Debt
78M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.64%
Revenue
31.4M
ROE
N/A
Book Value
22.9M
P/B Ratio
0.93
Cash Flow
N/A
Earnings
2.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
3.70
Current Revenue Per Employee
201447.55
Dividends Per Share - Security
N/A
EBITDA
25.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.63
Revenue To Assets
12.05
Shares Held By Institutions
73.9M
Shares Outstanding - Current
5.79M
Total Liabilities
107M
Total Volume MTD
N/A
Value
1
Gain YTD
-83.188
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company which engages in developing human antibodies for treating infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
61 North Beacon Street
Phone
+1 857 529-8300
Employees
93
Web
https://www.x4pharma.com